Irreversible electroporation in liver and pancreatic cancer

Irreversible electroporation in liver and pancreatic cancer
Country
Agency
Year work was carried out
Linkk
Details of use
Austria
LBI-HTA
2019
National adaptation. Made no changes. Added executive summary in German.
Austria
GOEG
2019
Dissemination to MoH.
Italy
ASSR RER
2019
National adaptation. Added local information and budget impact / cost-effectiveness analysis.
Italy
AGENAS
2019
Ongoing
Translation of the report summary.
Slovakia
UNIBA
2019
National adaptation. Added local information and budget impact / cost-effectiveness analysis.
Spain
AVALIA
2019
National adaptation. Added local information.
Spain
SCS
2019
Assessment disseminated to clinicians.
United Kingdom (England)
NICE
2019
Read the assessment for background information. EUnetHTA assessments are included in NHS Evidence.
United Kingdom (Scotland)
SHTG
2019
Dissemination. Alerted clinicians in country working in this area. Included in regular ‘horizon scanning’ update sent to external stakeholders.
This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.